Stock Price
3.68
Daily Change
-0.03 -0.81%
Monthly
1.38%
Yearly
8.27%
Q1 Forecast
3.54

Acasti Pharma reported $-938K in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Acasti Pharma USD -938K 2.42M Sep/2025
Addus HomeCare USD 22.85M 796K Sep/2025
Amarin USD -7.74M 6.4M Sep/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Option Care Health USD 51.82M 1.29M Sep/2025
Organigram Holdings CAD -37.96M 31.67M Sep/2025
Tilray USD -44.93M 44.61M Sep/2025